Document Detail


Predicting irreversible left ventricular dysfunction after acute myocardial infarction.
MedLine Citation:
PMID:  19406260     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Patients with reduced left ventricular ejection fractions (LVEFs) and previous myocardial infarctions or heart failure are at increased mortality risk. Implantable cardioverter-defibrillators may mitigate this risk. The aim of this study was to identify patient characteristics at the time of presentation with ST elevation myocardial infarction (STEMI) that predict irreversible left ventricular dysfunction. From January 2003 to December 2005, patients presenting with STEMIs and an LVEFs after percutaneous coronary intervention <or=0.4 were included (n = 118). Clinical, angiographic, and electrocardiographic characteristics at the time of STEMI were evaluated to predict LVEF at >or=90 days. Multivariate analysis identified post-percutaneous coronary intervention LVEF <or=0.3 (odds ratio 5.4, 95% confidence interval 2.1 to 14.1, p = 0.001), presentation with Killip class >I (odds ratio 4.4, 95% confidence interval 1.5 to 12.6, p = 0.006), and Q waves on postrevascularization electrocardiography (odds ratio 6.3, 95% confidence interval 1.5 to 26.5, p = 0.011) to be significantly more common in the group with LVEFs <or=0.3 at >or=90 days. The presence of all 3 factors, present in 14 patients (12%), had a positive predictive value of 100% that LVEF would be <or=0.3 at >or=90 days. In conclusion, in patients with STEMIs referred for catheterization, a post-percutaneous coronary intervention LVEF <or=0.3, presentation with Killip class >I, and pathologic Q waves after revascularization each predicted that the LVEF measured at >or=90 days would remain <or=0.3. The presence of all 3 features had a positive predictive value of 100%. These findings may identify a high-risk group of patients who might benefit from early aggressive therapy such as an implantable cardioverter-defibrillator.
Authors:
Daniel R Frisch; Evaldas Giedrimas; Satishkumar Mohanavelu; Amy Shui; Kalon K L Ho; C Michael Gibson; Mark E Josephson; Peter J Zimetbaum
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  The American journal of cardiology     Volume:  103     ISSN:  1879-1913     ISO Abbreviation:  Am. J. Cardiol.     Publication Date:  2009 May 
Date Detail:
Created Date:  2009-05-01     Completed Date:  2009-06-12     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0207277     Medline TA:  Am J Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1206-9     Citation Subset:  AIM; IM    
Affiliation:
Division of Cardiology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA. daniel.frisch@jefferson.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Age Distribution
Aged
Angioplasty, Transluminal, Percutaneous Coronary / adverse effects,  methods*
Cohort Studies
Confidence Intervals
Coronary Angiography
Electrocardiography*
Female
Follow-Up Studies
Heart Function Tests
Humans
Incidence
Logistic Models
Male
Middle Aged
Multivariate Analysis
Myocardial Infarction / complications*,  diagnosis*,  therapy
Odds Ratio
Predictive Value of Tests
Probability
Registries
Retrospective Studies
Risk Assessment
Severity of Illness Index
Sex Distribution
Stroke Volume
Survival Analysis
Ventricular Dysfunction, Left / epidemiology*,  etiology*,  physiopathology

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Impact of gender and antithrombin strategy on early and late clinical outcomes in patients with non-...
Next Document:  Impact of gender and age on in vivo virtual histology-intravascular ultrasound imaging plaque charac...